Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Experimental gene therapy of human colon cancer
R. J. Bold
, R. E. Warren
, J. Ishizuka
, Y. S. Cho-Chung
,
C. M. Townsend
, J. C. Thompson
, R. J. Joehl
, E. D. Whitman
Surgery
Research output
:
Contribution to journal
›
Article
›
peer-review
13
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Experimental gene therapy of human colon cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antisense Oligonucleotides
100%
Gene Therapy
100%
Cyclic Adenosine Monophosphate (cAMP)
100%
Human Colon Cancer
100%
Protein Kinase
50%
HCT116 Cells
50%
Human Colon Cancer Cells
37%
LoVo Cells
37%
Gastrin
25%
Mediated Growth
25%
Regulatory Subunit
25%
Cancer Cells
12%
Growth Inhibition
12%
New Therapeutic Approaches
12%
Western Blotting
12%
Signal Transduction Pathway
12%
Cell number
12%
Protein Level
12%
Cellular Proteins
12%
Relative Amount
12%
Target mRNA
12%
Northern Blotting
12%
LoVo
12%
Tritiated Thymidine
12%
Effects on Growth
12%
HCT116
12%
Protein Translation
12%
Membrane Permeable
12%
Sequence-specific Binding
12%
Thymidine Incorporation
12%
Basal Growth
12%
Dual Effect
12%
Inhibit Growth
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclic AMP
100%
Antisense Oligodeoxynucleotide
100%
Colon Carcinoma
100%
Cyclic AMP Dependent Protein Kinase
50%
Gastrin
25%
Messenger RNA
25%
Malignant Neoplasm
12%
Cell Protein
12%
Thymidine
12%
Immunology and Microbiology
Antisense
100%
Colon
100%
Cancer Cell
50%
Kinase A
50%
Gastrin
25%
Signal Transduction
12%
DNA Synthesis
12%
Northern Blotting
12%
Cell Count
12%
Translation (Protein Synthesis)
12%